WAM
ANIP icon

Wolverine Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Wolverine Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,000
Closed -$140K – 1330
2017
Q2 		$140K Sell
3,000
-31,600
-91% -$1.52M ﹤0.01% 1000
2017
Q1 		$1.71M Buy
34,600
+3,000
+9% +$168K 0.03% 424
2016
Q4 		$1.92M Buy
31,600
+29,500
+1,405% +$1.8M 0.02% 410
2016
Q3 		$139K Buy
2,100
+100
+5% +$6.25K ﹤0.01% 930
2016
Q2 		$111K Buy
2,000
+1,950
+3,900% +$94.8K ﹤0.01% 964
2016
Q1 		$2K Buy
+50
New +$1.7K ﹤0.01% 1155
2015
Q4 		– Sell
-455
Closed -$730K – 1679
2015
Q3 		$730K Buy
455
+224
+97% +$12.7K 0.02% 589
2015
Q2 		$73K Buy
+231
New +$13.7K ﹤0.01% 1208

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return